Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Window of Opportunity Trial of Intratumoral Injection of Copaxone® in Patients With Percutaneously Accessible Tumors

NCT03982212 is registered in ClinicalTrials.gov with University of Kansas Medical Center as lead sponsor.

NCT NCT03982212
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03982212 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Window of Opportunity Trial of Intratumoral Injection of Copaxone® in Patients With Percutaneously Accessible Tumors
Lead sponsor
University of Kansas Medical Center
Phase
Phase 1
Overall status
Unknown status
Start date
July 26, 2019
Completion date
July 31, 2024
Enrollment
10 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

basal cell carcinoma, cutaneous squamous cell carcinoma, squamous cell carcinoma